Predicting the Prevalence of Alternative Warfarin Tautomers in Solution
Warfarin, a widely used oral anticoagulant, is prescribed as a racemic mixture. Each enantiomer of neutral Warfarin can exist in 20 possible tautomeric states leading to complex pharmacokinetics and uncertainty as to the relevant species under different conditions. Here, the ability of alternative c...
Gespeichert in:
Veröffentlicht in: | Journal of chemical theory and computation 2018-08, Vol.14 (8), p.4405-4415 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 4415 |
---|---|
container_issue | 8 |
container_start_page | 4405 |
container_title | Journal of chemical theory and computation |
container_volume | 14 |
creator | Malde, Alpeshkumar K. Stroet, Martin Caron, Bertrand Visscher, Koen M. Mark, Alan E. |
description | Warfarin, a widely used oral anticoagulant, is prescribed as a racemic mixture. Each enantiomer of neutral Warfarin can exist in 20 possible tautomeric states leading to complex pharmacokinetics and uncertainty as to the relevant species under different conditions. Here, the ability of alternative computational approaches to predict the preferred tautomeric form(s) of neutral Warfarin in different solvents is examined. It is shown that varying the method used to estimate the heat of formation in vacuum (direct or via homodesmic reactions), whether entropic corrections were included, and the method used to estimate the free enthalpy of solvation (i.e., PCM, COSMO, or SMD implicit models or explicit solvent) lead to large differences in the predicted rank and relative populations of the tautomers. In this case, only a combination of the enthalpy of formation using homodesmic reactions and explicit solvent to estimate the free enthalpy of solvation yielded results compatible with the available experimental data. The work also suggests that a small but significant subset of the possible Warfarin tautomers are likely to be physiologically relevant. |
doi_str_mv | 10.1021/acs.jctc.8b00453 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2068925919</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2166741432</sourcerecordid><originalsourceid>FETCH-LOGICAL-a406t-5f5ab988e913a34508b36905998cdb739c8c9d1d46dc983d6764f82c8275d7a23</originalsourceid><addsrcrecordid>eNp1kEtLAzEURoMotlb3rmTAjQun5jWZZFmKVqGgYMVlyCQZnTKPmmQK_ntT-1gIZpNcON93yQHgEsExghjdKe3HSx30mBcQ0owcgSHKqEgFw-z48EZ8AM68X0JICMXkFAywiIcgPgSzF2dNpUPVfiTh0yZxXKvattomXZlM6mBdq0K1tsm7cqVyVZssVB-6xjqfxOG1q_tQde05OClV7e3F7h6Bt4f7xfQxnT_PnqaTeaooZCHNykwVgnMrEFGEZpAXhAmYCcG1KXIiNNfCIEOZ0YITw3JGS441x3lmcoXJCNxse1eu--qtD7KpvLZ1rVrb9V5iyLjAmUAiotd_0GXXx9_UkUKM5RRRsimEW0q7zntnS7lyVaPct0RQbiTLKFluJMud5Bi52hX3RWPNIbC3GoHbLfAb3S_9t-8HpSCHAA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2166741432</pqid></control><display><type>article</type><title>Predicting the Prevalence of Alternative Warfarin Tautomers in Solution</title><source>ACS Publications</source><creator>Malde, Alpeshkumar K. ; Stroet, Martin ; Caron, Bertrand ; Visscher, Koen M. ; Mark, Alan E.</creator><creatorcontrib>Malde, Alpeshkumar K. ; Stroet, Martin ; Caron, Bertrand ; Visscher, Koen M. ; Mark, Alan E.</creatorcontrib><description>Warfarin, a widely used oral anticoagulant, is prescribed as a racemic mixture. Each enantiomer of neutral Warfarin can exist in 20 possible tautomeric states leading to complex pharmacokinetics and uncertainty as to the relevant species under different conditions. Here, the ability of alternative computational approaches to predict the preferred tautomeric form(s) of neutral Warfarin in different solvents is examined. It is shown that varying the method used to estimate the heat of formation in vacuum (direct or via homodesmic reactions), whether entropic corrections were included, and the method used to estimate the free enthalpy of solvation (i.e., PCM, COSMO, or SMD implicit models or explicit solvent) lead to large differences in the predicted rank and relative populations of the tautomers. In this case, only a combination of the enthalpy of formation using homodesmic reactions and explicit solvent to estimate the free enthalpy of solvation yielded results compatible with the available experimental data. The work also suggests that a small but significant subset of the possible Warfarin tautomers are likely to be physiologically relevant.</description><identifier>ISSN: 1549-9618</identifier><identifier>EISSN: 1549-9626</identifier><identifier>DOI: 10.1021/acs.jctc.8b00453</identifier><identifier>PMID: 29999318</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><subject>Anticoagulants ; Enantiomers ; Enthalpy ; Heat of formation ; Pharmacology ; Solvation ; Solvents ; Tautomers ; Warfarin</subject><ispartof>Journal of chemical theory and computation, 2018-08, Vol.14 (8), p.4405-4415</ispartof><rights>Copyright American Chemical Society Aug 14, 2018</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a406t-5f5ab988e913a34508b36905998cdb739c8c9d1d46dc983d6764f82c8275d7a23</citedby><cites>FETCH-LOGICAL-a406t-5f5ab988e913a34508b36905998cdb739c8c9d1d46dc983d6764f82c8275d7a23</cites><orcidid>0000-0001-5880-4798 ; 0000-0002-8181-1619</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jctc.8b00453$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jctc.8b00453$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2751,27055,27903,27904,56716,56766</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/29999318$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Malde, Alpeshkumar K.</creatorcontrib><creatorcontrib>Stroet, Martin</creatorcontrib><creatorcontrib>Caron, Bertrand</creatorcontrib><creatorcontrib>Visscher, Koen M.</creatorcontrib><creatorcontrib>Mark, Alan E.</creatorcontrib><title>Predicting the Prevalence of Alternative Warfarin Tautomers in Solution</title><title>Journal of chemical theory and computation</title><addtitle>J. Chem. Theory Comput</addtitle><description>Warfarin, a widely used oral anticoagulant, is prescribed as a racemic mixture. Each enantiomer of neutral Warfarin can exist in 20 possible tautomeric states leading to complex pharmacokinetics and uncertainty as to the relevant species under different conditions. Here, the ability of alternative computational approaches to predict the preferred tautomeric form(s) of neutral Warfarin in different solvents is examined. It is shown that varying the method used to estimate the heat of formation in vacuum (direct or via homodesmic reactions), whether entropic corrections were included, and the method used to estimate the free enthalpy of solvation (i.e., PCM, COSMO, or SMD implicit models or explicit solvent) lead to large differences in the predicted rank and relative populations of the tautomers. In this case, only a combination of the enthalpy of formation using homodesmic reactions and explicit solvent to estimate the free enthalpy of solvation yielded results compatible with the available experimental data. The work also suggests that a small but significant subset of the possible Warfarin tautomers are likely to be physiologically relevant.</description><subject>Anticoagulants</subject><subject>Enantiomers</subject><subject>Enthalpy</subject><subject>Heat of formation</subject><subject>Pharmacology</subject><subject>Solvation</subject><subject>Solvents</subject><subject>Tautomers</subject><subject>Warfarin</subject><issn>1549-9618</issn><issn>1549-9626</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><recordid>eNp1kEtLAzEURoMotlb3rmTAjQun5jWZZFmKVqGgYMVlyCQZnTKPmmQK_ntT-1gIZpNcON93yQHgEsExghjdKe3HSx30mBcQ0owcgSHKqEgFw-z48EZ8AM68X0JICMXkFAywiIcgPgSzF2dNpUPVfiTh0yZxXKvattomXZlM6mBdq0K1tsm7cqVyVZssVB-6xjqfxOG1q_tQde05OClV7e3F7h6Bt4f7xfQxnT_PnqaTeaooZCHNykwVgnMrEFGEZpAXhAmYCcG1KXIiNNfCIEOZ0YITw3JGS441x3lmcoXJCNxse1eu--qtD7KpvLZ1rVrb9V5iyLjAmUAiotd_0GXXx9_UkUKM5RRRsimEW0q7zntnS7lyVaPct0RQbiTLKFluJMud5Bi52hX3RWPNIbC3GoHbLfAb3S_9t-8HpSCHAA</recordid><startdate>20180814</startdate><enddate>20180814</enddate><creator>Malde, Alpeshkumar K.</creator><creator>Stroet, Martin</creator><creator>Caron, Bertrand</creator><creator>Visscher, Koen M.</creator><creator>Mark, Alan E.</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SC</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>JQ2</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-5880-4798</orcidid><orcidid>https://orcid.org/0000-0002-8181-1619</orcidid></search><sort><creationdate>20180814</creationdate><title>Predicting the Prevalence of Alternative Warfarin Tautomers in Solution</title><author>Malde, Alpeshkumar K. ; Stroet, Martin ; Caron, Bertrand ; Visscher, Koen M. ; Mark, Alan E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a406t-5f5ab988e913a34508b36905998cdb739c8c9d1d46dc983d6764f82c8275d7a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Anticoagulants</topic><topic>Enantiomers</topic><topic>Enthalpy</topic><topic>Heat of formation</topic><topic>Pharmacology</topic><topic>Solvation</topic><topic>Solvents</topic><topic>Tautomers</topic><topic>Warfarin</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Malde, Alpeshkumar K.</creatorcontrib><creatorcontrib>Stroet, Martin</creatorcontrib><creatorcontrib>Caron, Bertrand</creatorcontrib><creatorcontrib>Visscher, Koen M.</creatorcontrib><creatorcontrib>Mark, Alan E.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Computer and Information Systems Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of chemical theory and computation</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Malde, Alpeshkumar K.</au><au>Stroet, Martin</au><au>Caron, Bertrand</au><au>Visscher, Koen M.</au><au>Mark, Alan E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predicting the Prevalence of Alternative Warfarin Tautomers in Solution</atitle><jtitle>Journal of chemical theory and computation</jtitle><addtitle>J. Chem. Theory Comput</addtitle><date>2018-08-14</date><risdate>2018</risdate><volume>14</volume><issue>8</issue><spage>4405</spage><epage>4415</epage><pages>4405-4415</pages><issn>1549-9618</issn><eissn>1549-9626</eissn><abstract>Warfarin, a widely used oral anticoagulant, is prescribed as a racemic mixture. Each enantiomer of neutral Warfarin can exist in 20 possible tautomeric states leading to complex pharmacokinetics and uncertainty as to the relevant species under different conditions. Here, the ability of alternative computational approaches to predict the preferred tautomeric form(s) of neutral Warfarin in different solvents is examined. It is shown that varying the method used to estimate the heat of formation in vacuum (direct or via homodesmic reactions), whether entropic corrections were included, and the method used to estimate the free enthalpy of solvation (i.e., PCM, COSMO, or SMD implicit models or explicit solvent) lead to large differences in the predicted rank and relative populations of the tautomers. In this case, only a combination of the enthalpy of formation using homodesmic reactions and explicit solvent to estimate the free enthalpy of solvation yielded results compatible with the available experimental data. The work also suggests that a small but significant subset of the possible Warfarin tautomers are likely to be physiologically relevant.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>29999318</pmid><doi>10.1021/acs.jctc.8b00453</doi><tpages>11</tpages><orcidid>https://orcid.org/0000-0001-5880-4798</orcidid><orcidid>https://orcid.org/0000-0002-8181-1619</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1549-9618 |
ispartof | Journal of chemical theory and computation, 2018-08, Vol.14 (8), p.4405-4415 |
issn | 1549-9618 1549-9626 |
language | eng |
recordid | cdi_proquest_miscellaneous_2068925919 |
source | ACS Publications |
subjects | Anticoagulants Enantiomers Enthalpy Heat of formation Pharmacology Solvation Solvents Tautomers Warfarin |
title | Predicting the Prevalence of Alternative Warfarin Tautomers in Solution |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T07%3A21%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predicting%20the%20Prevalence%20of%20Alternative%20Warfarin%20Tautomers%20in%20Solution&rft.jtitle=Journal%20of%20chemical%20theory%20and%20computation&rft.au=Malde,%20Alpeshkumar%20K.&rft.date=2018-08-14&rft.volume=14&rft.issue=8&rft.spage=4405&rft.epage=4415&rft.pages=4405-4415&rft.issn=1549-9618&rft.eissn=1549-9626&rft_id=info:doi/10.1021/acs.jctc.8b00453&rft_dat=%3Cproquest_cross%3E2166741432%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2166741432&rft_id=info:pmid/29999318&rfr_iscdi=true |